首页> 外文期刊>Biotechnology healthcare >Familial hypercholesterolemia captures gene test controversies.
【24h】

Familial hypercholesterolemia captures gene test controversies.

机译:家族性高胆固醇血症记录了基因测试的争议。

获取原文
获取原文并翻译 | 示例
           

摘要

You can't watch This Week with George Steph-anopoulos, or riffle through The Economist without being inundated with ads for statins. Hypercholesterolemia may be the most medicated disease, and anyone on statins likely got there because of a fondness for high-dietary cholesterol, saturated fat, and a sedentary lifestyle. Familial hypercholesterolemia (FH), on the other hand, is caused by inherited mutations in the LDL receptor gene. Someone with heterozygous FH (one parent contributes a genetic mutation) typically has a total cholesterol count of 300 to 400 milligrams per deciliter and a level of low-density lipoprotein (LDL), the "bad" cholesterol, in excess of 200 mg/dL. Homozygous FH (both parents contribute genetic mutations) is characterized by a total cholesterol level that can reach 1,000 mg/dL. Either type is deadlier than acquired hypercholesterolemia.
机译:您无法与George Steph-anopoulos一起观看“本周”节目,也不能在没有被他汀类药物广告泛滥的情况下通过《经济学人》一探而过。高胆固醇血症可能是治疗最多的疾病,他汀类药物的所有人都可能因为对高饮食胆固醇,饱和脂肪和久坐的生活方式的爱好而到达那里。另一方面,家族性高胆固醇血症(FH)是由LDL受体基因的遗传突变引起的。具有杂合性FH(一个父母造成了基因突变)的人通常具有300到400毫克/分升的总胆固醇计数,并且低密度脂蛋白(LDL)(即“坏”胆固醇)水平超过200 mg / dL 。纯合子FH(父母双方均贡献基因突变)的特征在于总胆固醇水平可以达到1,000 mg / dL。两种类型都比获得性高胆固醇血症更致命。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号